Minaris Advanced Therapies: Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR-T Program

Five-year collaboration supports consistent clinical supply for Phase 1A/1B GI cancer studyPHILADELPHIA and MELBOURNE, Australia, April 21, 2026 /PRNewswire/ -- Minaris, a global cell and gene ...

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...

Mesoblast Limited: Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an ...

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented ...
Oncology Nurse Advisor

Late Mixed Chimerism Levels Predict Relapse Risk After HSCT in AML and MDS

Serial post-transplant chimerism assessment provided more reliable prognostic insight than a single early measurement.
Oncology Nurse Advisor

Updates and Considerations in Using Chimeric Antigen Receptor T-Cell Therapies

An update on CAR-T therapies for MM and B-cell NHL presented at the 2026 ONA Summit highlighted the integral role of oncology nurses in ensuring patients achieve optimal outcomes.
BioWorld

Chimerix buyout a win for Jazz with FDA nod for rare glioma drug

Jazz Pharmaceuticals plc is prepped and ready for launch following U.S. FDA accelerated approval of dordaviprone as the first systemic therapy for H3 K27M-mutant diffuse glioma. Branded Modeyso, the ...
Independent Online

Did you know? Your child's DNA might be hanging out in your body – 5 mind-blowing facts about microchimerism

You've probably seen those health "did you know?" videos on TikTok. Here's a shocking fact for moms: Did you know, a child's DNA can linger in your body for years after childbirth? And if you’re the ...
American Banker

Chime files for U.S. IPO on heels of office expansion

Chime's IPO filing signals a potential reopening of the IPO window for the U.S. market, which is sharply rising after news of a U.S-China trade deal and a 90-day pause on reciprocal tariffs for ...
Investing

Chimerix stock soars to 52-week high, hits $8.53

Chimerix stock soars to 52-week high, hits $8.53 ...
Benzinga.com

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

On Tuesday, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) agreed to acquire Chimerix Inc (NASDAQ:CMRX) for $8.55 per share in cash, representing a total consideration of approximately $935 million. Both ...
STAT

Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...